BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20888755)

  • 21. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
    Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
    J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritoneal carcinomatosis cytoreductive surgery and HIPEC: a ray of hope for cure.
    Spiliotis JD
    Hepatogastroenterology; 2010; 57(102-103):1173-7. PubMed ID: 21410053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin.
    Ceelen WP
    Surg Technol Int; 2005; 14():125-30. PubMed ID: 16525964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.
    Glehen O; Gilly FN; Boutitie F; Bereder JM; Quenet F; Sideris L; Mansvelt B; Lorimier G; Msika S; Elias D;
    Cancer; 2010 Dec; 116(24):5608-18. PubMed ID: 20737573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].
    Iesalnieks I; Kullmann F; Dahlke M; Ghali N; Agha A; von Breitenbuch P; Schoelmerich J; Schlitt HJ; Piso P
    Z Gastroenterol; 2006 Dec; 44(12):1237-45. PubMed ID: 17163375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment for peritoneal carcinomatosis from gastric cancer.
    Yonemura Y; Endou Y; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Miura M; Li Y
    Eur J Surg Oncol; 2010 Dec; 36(12):1131-8. PubMed ID: 20933363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis.
    Spiliotis J; Rogdakis A; Vaxevanidou A; Datsis A; Zacharis G; Christopoulou A
    J BUON; 2009; 14(2):259-64. PubMed ID: 19650176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
    Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
    Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.
    Elias D; Quenet F; Goéré D
    Surg Oncol Clin N Am; 2012 Oct; 21(4):611-23. PubMed ID: 23021719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
    Avital I; Brücher BL; Nissan A; Stojadinovic A
    Surg Oncol Clin N Am; 2012 Oct; 21(4):665-88. PubMed ID: 23021723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study.
    Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
    Ann Surg; 2011 Jul; 254(1):125-30. PubMed ID: 21502859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].
    Eveno C; Dagois S; Guillot E; Gornet JM; Pocard M
    Bull Cancer; 2008 Jan; 95(1):141-5. PubMed ID: 18230580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].
    Kavanagh M; Ouellet JF;
    Bull Cancer; 2006 Sep; 93(9):867-74. PubMed ID: 16980229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis.
    Capone A; Valle M; Proietti F; Federici O; Garofalo A; Petrosillo N
    J Surg Oncol; 2007 Nov; 96(6):507-13. PubMed ID: 17708508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
    In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.
    Losa F; Barrios P; Salazar R; Torres-Melero J; Benavides M; Massuti T; Ramos I; Aranda E
    Clin Transl Oncol; 2014 Feb; 16(2):128-40. PubMed ID: 23740133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.